[High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia]

MeSH terms

• Acute Disease
• Adolescent
• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Asparaginase / administration & dosage
• Asparaginase / adverse effects
• Child
• Cytarabine / administration & dosage
• Cytarabine / adverse effects
• Female
• Humans
• Leukemia / drug therapy*
• Male
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy*
• Remission Induction